<DOC>
	<DOC>NCT01634789</DOC>
	<brief_summary>The purpose of this study is to evaluate 3 test formulations relative to a reference formulation.</brief_summary>
	<brief_title>A Pilot Bioavailability Study of 3 Test Tablet Formulations of Bazedoxifene Compared With A Reference Tablet Formulation of Bazedoxifene/Conjugated Estrogens in Healthy Postmenopausal Women</brief_title>
	<detailed_description />
	<mesh_term>Estrogens, Conjugated (USP)</mesh_term>
	<mesh_term>Estrogens</mesh_term>
	<mesh_term>Bazedoxifene</mesh_term>
	<criteria>Generally healthy postmenopausal women Body mass index (BMI) in the range of 18.0 to 35.0 kg/m2 and body weight &gt;= 50 kg Pregnant or nursing females; females of childbearing potential</criteria>
	<gender>Female</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>bioavailability</keyword>
</DOC>